Janney Montgomery Scott
AMRX icon

Janney Montgomery Scott’s Amneal Pharmaceuticals AMRX Stock Holding History

Janney Montgomery Scott’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$481K Buy
27,770
+401
+1% +$5.5K ﹤0.01% 2413
2026
Q1 		$340K Sell
27,369
-3,258
-11% -$43.7K ﹤0.01% 2299
2025
Q4 		$386K Buy
30,627
+7,477
+32% +$85.5K ﹤0.01% 2383
2025
Q3 		$232K Hold
23,150
– – ﹤0.01% 2647
2025
Q2 		$187K Buy
23,150
+3,800
+20% +$28.6K ﹤0.01% 2579
2025
Q1 		$162K Buy
19,350
+4,100
+27% +$34.2K ﹤0.01% 2560
2024
Q4 		$121K Buy
+15,250
New +$128K ﹤0.01% 2612
2024
Q3 		– Sell
-11,960
Closed -$76K – 2655
2024
Q2 		$76K Buy
+11,960
New +$75.9K ﹤0.01% 2542

Other funds holding AMRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Janney Montgomery Scott's AMRX Position: Q2 2026 in Review

Janney Montgomery Scott increased its Amneal Pharmaceuticals (AMRX) stake by 1.5% in Q2 2026, buying an estimated $5.5K and bringing the position to 27,770 shares worth $481K. The position accounts for ﹤0.01% of the portfolio, ranked #2413.

Janney Montgomery Scott first reported a position in AMRX in Q2 2024 and has held it in 8 quarters since. 310 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

  • Janney Montgomery Scott held 27,770 shares of Amneal Pharmaceuticals worth $481K as of Q2 2026.
  • Janney Montgomery Scott bought 401 Amneal Pharmaceuticals shares in Q2 2026, an estimated $5.5K.
  • Amneal Pharmaceuticals made up ﹤0.01% of Janney Montgomery Scott's portfolio in Q2 2026, its #2413 holding.
  • Janney Montgomery Scott first reported a position in Amneal Pharmaceuticals in Q2 2024 and has held it in 8 quarters since.
  • 310 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on Janney Montgomery Scott's 13F filing for Q2 2026, filed 5 Aug 2026.